The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.
about
Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionThe role of cannabinoid transmission in emotional memory formation: implications for addiction and schizophreniaNeurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.Role of the endogenous cannabinoid system in nicotine addiction: novel insights.The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.Comorbid Cannabis and Tobacco Use in Adolescents and AdultsPutative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a StressorThe future of endocannabinoid-oriented clinical research after CB1 antagonists.Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.The genetic basis of the endocannabinoid system and drug addiction in humans.Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction.Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by nicotine.Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
P2860
Q28283718-9795D5E9-F298-41D6-B6AB-4EE5C5C074FFQ33820114-417A0FDD-3502-47EA-B9B5-0315E9F8F37AQ34012381-D01AE173-550F-4EAC-A84E-D7B4C9C7C3E8Q35216481-108059F1-500F-4713-98B5-4765B73AE4F4Q36176513-7719F417-1F80-4ACA-93BC-9834C477D859Q36884258-A4FB4F84-5B2C-43C6-BA7B-374E5081EF7DQ37088001-97AC6F53-6415-4DBE-B528-FCFBF8552F35Q37226111-2EF7F9E8-00D2-41DC-887D-63CC292F4093Q37356740-6C9DA552-B8F5-410D-9C04-1944AD85309DQ37936694-A8A1F23E-EE8D-4B11-9CC6-F11F41C2A3B7Q38636791-BC23C20C-EF16-47BB-A76A-67552ACE1A30Q38686274-960B827E-C681-40EF-9DAE-2B085773EEC4Q41489097-5FE6B99E-0545-46CF-99AD-47146F2B4EB1Q47225379-042231B8-7E98-41D3-9CB6-57992C864EB7Q48139928-A776E6C3-C5F7-4F0A-8CE8-160418B05B0D
P2860
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The endocannabinoid system: a ...... reatment of tobacco addiction.
@en
The endocannabinoid system: a ...... reatment of tobacco addiction.
@nl
type
label
The endocannabinoid system: a ...... reatment of tobacco addiction.
@en
The endocannabinoid system: a ...... reatment of tobacco addiction.
@nl
prefLabel
The endocannabinoid system: a ...... reatment of tobacco addiction.
@en
The endocannabinoid system: a ...... reatment of tobacco addiction.
@nl
P2093
P2860
P50
P1476
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction
@en
P2093
Benoit Forget
Maria Scherma
Steven R Goldberg
Walter Fratta
P2860
P304
P356
10.2174/187152708786927859
P577
2008-11-01T00:00:00Z